Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
The latest announcement is out from Oxford BioMedica ( (GB:OXB) ).
Oxford BioMedica has appointed Jefferies International Limited as a Joint Corporate Broker and Joint Financial Adviser alongside RBC Capital Markets. This strategic move is expected to bolster OXB’s financial advisory capabilities, potentially enhancing its market operations and industry positioning.
More about Oxford BioMedica
OXB (Oxford BioMedica) is a contract development and manufacturing organization (CDMO) specializing in cell and gene therapy. With over 25 years of expertise in viral vectors, the company collaborates with leading pharmaceutical and biotechnology firms to enable the delivery of life-changing therapies globally. OXB offers advanced technologies for viral vector manufacturing and has facilities across the UK, France, and the US.
YTD Price Performance: -2.46%
Average Trading Volume: 3,493
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $535.7M
For detailed information about OXB stock, go to TipRanks’ Stock Analysis page.
